23andMe shares slide more than 15% as lower services revenue hits Q3 results
Shares of 23andMe Holding Co. fell 15.8% Thursday after the DNA-testing company fiscal third-quarter sales declined 33%, weighed down by lower consumer services and research revenue. The stock’s performance puts 23andMe ME, shares on pace for their biggest daily percentage decline since Nov. 9,…
#23andmeholdingco #dowjonesmarketdata #gskplc #gsk #pgs #px